Chamber and committees

Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

The National Gender Identity Healthcare Reference Group continues to meet and make progress against all the commitments set out within the referenced December 2021 Strategic Action Framework. This includes:

• Healthcare Improvement Scotland developing standards for gender identity healthcare for NHS Scotland;
• NHS Education Scotland developing a Transgender Health Knowledge and Skills framework for NHS staff;
• Public Health Scotland working with Health Boards to deliver publication of waiting times data by them; and
• Grant funding to the University of Glasgow to administer a programme of research on gender identity healthcare.

Decisions on clinical pathways are not for the Scottish Government. These decisions are for clinicians, based on the best evidence available, through the appropriate clinical governance structures.

The Scottish Government is unaware of any discussions between NHS Scotland Health Boards and the UK Government regarding the prescription of puberty-suppressing hormones as a treatment option for gender dysphoria.

We recognise the ongoing impact that adverse weather conditions are having on Scotland’s agricultural industry – conditions that are a direct result of climate change.

The poor weather conditions experienced in the early spring will be presenting challenges to farmers and crofters at the time of peak lambing and calving, and will be impacting the ability to sow crops. The Farm Advisory Service, funded by the Scottish Government, provides resources for farmers and crofters in responding to the wet weather this year.

The Farm Advisory Service is also signposting people towards the charity RSABI. RSABI provide practical, emotional and financial support to all people involved in the Scottish agricultural industry.

The Scottish Government’s Aviation Statement, which will be published shortly, will set out actions that the Scottish Government will take to help achieve our aviation emissions reduction targets. As noted in the Climate Change Committee’s report, aviation decarbonisation will require UK-wide co-operation and progress across all aviation emissions mitigation solutions.

The Scottish Government’s Aviation Statement, which will be published shortly, will set out actions that the Scottish Government will take to help achieve our aviation emissions reduction targets. Our Hydrogen Innovation Scheme previously provided £150,000 of funding to Glasgow Airport for a study to explore the feasibility of a hydrogen production, storage and distribution hub that would support zero emission transport at the airport. The Scottish Government has also provided grant funding to Edinburgh Airport to support its low carbon energy system.

The Scottish Government does not hold the detail of this funding. Local decisions on how to allocate funding is the responsibility of NHS Boards.

Public Health Scotland (PHS) collects data and provides analysis on NHS spending and the cost of running services across the 14 territorial health boards, the Golden Jubilee, and the State Hospital. This information is published annually in the Scottish Health Service Costs release (‘Costs Book’).

The data has a breakdown of Hospital, Community, Family Health Services, and subsequent breakdown into sub-categories, however it does not specifically provide funding in preventative and early interventions (also note the difference between expenditure per Cost Book and funding per the question).

The Scottish Government understands that Public Health Scotland intends to publish, as official statistics in development, gender identity clinic waiting times information provided by NHS Grampian, NHS Greater Glasgow and Clyde, NHS Highland and NHS Lothian in late summer 2024. This will be subject to the necessary data quality and completeness standards being met.

The Scottish Government welcomes the publication, on 10 April, of the final report and recommendations of the NHS England-commissioned Independent Review of Gender Identity Services for Children and Young People, chaired by Dr Hiliary Cass (‘the Cass Review’).

The findings of the review, and the associated systematic review papers, are being closely considered by both the Scottish Government and Health Boards in Scotland in the context of how such healthcare is best delivered here.

On 18 April, in a joint statement, NHS Greater Glasgow and Clyde and NHS Lothian confirmed that both Boards have paused any new prescription of puberty-supressing hormones and cross-sex hormones for young people as a treatment option for gender dysphoria.

The small number of patients directly impacted by this change, and their families, were notified in advance of this statement. It is right that they were the first to hear about it, sensitively and from the services caring for them, before a public statement was made.

The adaptive framework under the new Bill will enable tailored provisions and support to be implemented to support our food producers and we continue to co-develop effective policies to deliver the Vision for Agriculture. As a framework Bill it will not set thresholds which could restrict future flexibility.

How these powers will be used are set out in the Bills associated Policy Memorandum and Explanatory notes .

Future eligibility criteria will be co-developed with partners through the Ag Reform Programme.